Sunshine Biopharma (SBFM) Shares Outstanding (2017 - 2026)
Sunshine Biopharma's (SBFM) quarterly Shares Outstanding (Entity) came in at $490594.0 in Q1 2026, up 81.2% YoY from $270754.0 in Q1 2025, and little changed on a QoQ basis from $490594.0 in Q4 2025.
Sunshine Biopharma (SBFM) Shares Outstanding (2017 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of Shares Outstanding (Entity) data on file, last reported at $490594.0 in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 81.2% year-over-year to $490594.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $490594.0 (up 81.2% YoY) and the FY2025 annual result came in at $490594.0, up 599.1% from the prior year.
- Shares Outstanding (Entity) was little changed at $490594.0 in Q1 2026, from $490594.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $490594.0 in Q4 2025 to a low of $264.0 in Q1 2022.
- A 5-year average of $139778.3 and a median of $3207.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 36.02% — and 2024, when it soared 9771.96%.
- Tracing SBFM's Shares Outstanding (Entity) over 5 years: stood at $759.0 in 2022, then jumped by 84.58% to $1401.0 in 2023, then soared by 4908.92% to $70175.0 in 2024, then surged by 599.1% to $490594.0 in 2025, then changed by 0.0% to $490594.0 in 2026.
- The last three Shares Outstanding (Entity) figures came in at $490594.0 (Q1 2026), $490594.0 (Q4 2025), and $455594.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Mar 31, 2026 | 490,594.00 |
| Dec 31, 2025 | 415,709.00 |
| Sep 30, 2025 | 455,594.00 |
| Jun 30, 2025 | 449,611.00 |
| Mar 31, 2025 | 270,329.00 |
| Dec 31, 2024 | 70,175.00 |
| Sep 30, 2024 | 126,756.00 |
| Jun 30, 2024 | 4,973.00 |
| Mar 31, 2024 | 3,207.00 |
| Dec 31, 2023 | 1,217.00 |
| Sep 30, 2023 | 1,285.00 |
| Jun 30, 2023 | 1,268.00 |
| Mar 31, 2023 | 1,102.00 |
| Dec 31, 2022 | 759.00 |
| Sep 30, 2022 | 944.00 |
| Jun 30, 2022 | 792.00 |
| Mar 31, 2022 | 264.00 |
| Dec 31, 2021 | 131.00 |
| Sep 30, 2021 | 127.00 |